Conflicts of Interest for Patient-Advocacy Organizations
Conflicts of Interest for Patient-Advocacy Organizations
复制标题
DOI:
10.1056/nejmsr1610625
复制
发表时间:
2017-03-02
影响因子:
158.5
通讯作者:
Schmidt, Harald
中科院分区:
文献类型:
--
作者:
McCoy, Matthew S.;Carniol, Michael;Schmidt, Harald
In this examination of 104 large patient-advocacy organizations, 83% receive financial support from drug, device, and biotechnology companies, and industry executives often serve on governing boards. The authors recommend more transparency about industry involvement.